XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Impact of adopting ASC 326
Common stock
Additional paid-in capital
Retained earnings
Retained earnings
Impact of adopting ASC 326
Accumulated other comprehensive income (loss)
Treasury stock
Total stockholders' equity attributable to parent
Total stockholders' equity attributable to parent
Impact of adopting ASC 326
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2021     12,934,966                
Beginning balance (in shares) at Dec. 31, 2021               848,016      
Beginning balance at Dec. 31, 2021 $ 275,303   $ 12,935 $ 143,521 $ 138,219   $ (3,606) $ (16,741) $ 274,328   $ 975
Increase (Decrease) in Stockholders' Equity                      
Net income 2,671       2,864       2,864   (193)
Other comprehensive loss (13,556)           (13,556)   (13,556)    
Dividends on common stock (2,059)       (2,059)       (2,059)    
Stock-based compensation 674     674         674    
Stock-based compensation related to equity method investment 104     104         104    
Common stock options exercised (in shares)     56,174                
Common stock options exercised 725   $ 56 669         725    
Ending balance (in shares) at Mar. 31, 2022     12,991,140                
Ending balance (in shares) at Mar. 31, 2022               848,016      
Ending balance at Mar. 31, 2022 263,862   $ 12,991 144,968 139,024   (17,162) $ (16,741) 263,080   782
Beginning balance (in shares) at Dec. 31, 2021     12,934,966                
Beginning balance (in shares) at Dec. 31, 2021               848,016      
Beginning balance at Dec. 31, 2021 275,303   $ 12,935 143,521 138,219   (3,606) $ (16,741) 274,328   975
Increase (Decrease) in Stockholders' Equity                      
Net income 5,462                    
Other comprehensive loss (25,814)                    
Ending balance (in shares) at Jun. 30, 2022     13,077,044                
Ending balance (in shares) at Jun. 30, 2022               848,016      
Ending balance at Jun. 30, 2022 252,910   $ 13,077 145,480 139,904   (29,420) $ (16,741) 252,300   610
Beginning balance (in shares) at Mar. 31, 2022     12,991,140                
Beginning balance (in shares) at Mar. 31, 2022               848,016      
Beginning balance at Mar. 31, 2022 263,862   $ 12,991 144,968 139,024   (17,162) $ (16,741) 263,080   782
Increase (Decrease) in Stockholders' Equity                      
Net income 2,791       2,956       2,956   (165)
Other comprehensive loss (12,258)           (12,258)   (12,258)    
Dividends on common stock (2,076)       (2,076)       (2,076)    
Stock-based compensation 757     757         757    
Stock-based compensation related to equity method investment 173     173         173    
Common stock options exercised (in shares)     30,200                
Common stock options exercised 392   $ 30 362         392    
Restricted stock units vested (in shares)     73,300                
Restricted stock units vested 0   $ 73 (73)         0    
Minimum tax withholding on restricted stock units issued (in shares)     (17,596)                
Minimum tax withholding on restricted stock units issued (691)   $ (17) (674)         (691)    
Redemption of and Stock purchase from noncontrolling interest (40)     (33)         (33)   (7)
Ending balance (in shares) at Jun. 30, 2022     13,077,044                
Ending balance (in shares) at Jun. 30, 2022               848,016      
Ending balance at Jun. 30, 2022 $ 252,910   $ 13,077 145,480 139,904   (29,420) $ (16,741) 252,300   610
Beginning balance (in shares) at Dec. 31, 2022 12,618,265   13,466,281                
Beginning balance (in shares) at Dec. 31, 2022 848,016             848,016      
Beginning balance at Dec. 31, 2022 $ 261,391 $ (6,642) $ 13,466 157,152 144,911 $ (6,642) (37,704) $ (16,741) 261,084 $ (6,642) 307
Increase (Decrease) in Stockholders' Equity                      
Net income 11,220       11,342       11,342   (122)
Other comprehensive loss 6,766           6,766   6,766    
Dividends on common stock (2,146)       (2,146)       (2,146)    
Stock-based compensation 831     831         831    
Stock-based compensation related to equity method investment 69     69         69    
Common stock options exercised (in shares)     4,450                
Common stock options exercised 70   $ 4 66         70    
Restricted stock units vested (in shares)     43,882                
Restricted stock units vested 0   $ 44 (44)         0    
Minimum tax withholding on restricted stock units issued (in shares)     (13,416)                
Minimum tax withholding on restricted stock units issued (243)   $ (13) (230)         (243)    
Ending balance (in shares) at Mar. 31, 2023     13,501,197                
Ending balance (in shares) at Mar. 31, 2023               848,016      
Ending balance at Mar. 31, 2023 $ 271,316   $ 13,501 157,844 147,465   (30,938) $ (16,741) 271,131   185
Beginning balance (in shares) at Dec. 31, 2022 12,618,265   13,466,281                
Beginning balance (in shares) at Dec. 31, 2022 848,016             848,016      
Beginning balance at Dec. 31, 2022 $ 261,391 $ (6,642) $ 13,466 157,152 144,911 $ (6,642) (37,704) $ (16,741) 261,084 $ (6,642) 307
Increase (Decrease) in Stockholders' Equity                      
Net income 19,218                    
Other comprehensive loss $ 3,240                    
Ending balance (in shares) at Jun. 30, 2023 12,719,823   13,567,839                
Ending balance (in shares) at Jun. 30, 2023 848,016             848,016      
Ending balance at Jun. 30, 2023 $ 274,297   $ 13,568 158,572 153,414   (34,464) $ (16,741) 274,349   (52)
Beginning balance (in shares) at Mar. 31, 2023     13,501,197                
Beginning balance (in shares) at Mar. 31, 2023               848,016      
Beginning balance at Mar. 31, 2023 271,316   $ 13,501 157,844 147,465   (30,938) $ (16,741) 271,131   185
Increase (Decrease) in Stockholders' Equity                      
Net income 7,998       8,112       8,112   (114)
Other comprehensive loss (3,526)           (3,526)   (3,526)    
Dividends on common stock (2,163)       (2,163)       (2,163)    
Stock-based compensation 792     792         792    
Stock-based compensation related to equity method investment 104     104         104    
Common stock options exercised (in shares)     3,000                
Common stock options exercised 43   $ 3 40         43    
Restricted stock units vested (in shares)     86,520                
Restricted stock units vested 0   $ 87 (87)         0    
Minimum tax withholding on restricted stock units issued (in shares)     (22,878)                
Minimum tax withholding on restricted stock units issued (438)   $ (23) (415)         (438)    
Redemption of and Stock purchase from noncontrolling interest $ 171     294         294   (123)
Ending balance (in shares) at Jun. 30, 2023 12,719,823   13,567,839                
Ending balance (in shares) at Jun. 30, 2023 848,016             848,016      
Ending balance at Jun. 30, 2023 $ 274,297   $ 13,568 $ 158,572 $ 153,414   $ (34,464) $ (16,741) $ 274,349   $ (52)